New - Data from the Imperial Clinical Program demonstrates ELUVIA more effective in diabetic patients  January 22, 2019    

Boston Scientific today announced diabetic
subanalysis results from the IMPERIAL trial in which patients treated with the ELUVIA™ Drug-Eluting Vascular Stent System demonstrated statistically significant lower rates of...

READ MORE